Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorState University of New York at Buffalo
About this trial
The study is a 2-arm randomized controlled trial among patients referred for kidney transplant evaluation at a single transplant center to compare the effects of a digital-analog intervention to increase living-donor kidney transplant access (KidneyTIME+) with or without human guide . Following consent and baseline assessment, participants are randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME+ intervention with or without human guide.
Eligibility criteria
Qualifiers
referred to the transplant center for a kidney transplant
aged 18 years and older
speaks English
Disqualifiers
Previously exposed to any component of the intervention
Listed for a kidney transplant at another center (multilisted)
Seeking multiorgan transplantation
Trial design
Treatments tested in this trial
- Digital education outreach intervention for kidney transplant access and human guide
- Digital education outreach intervention for kidney transplant access only (unguided)
Treatment groups
430 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov